Global pharmaceutical leader, Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), today ...

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced ...

Lupin management remains confident that the India formulations business will continue to outperform IPM by 1.2-1.3 times, supported by strong sales force and pipeline of new product launches.

FILE PHOTO: The logo of Lupin, India's No. 2 drugmaker, is seen on the facade of its pharmaceutical plant in Verna FILE PHOTO: The logo of Lupin, India's No. 2 drugmaker, is seen on the facade of its ...

Lupin Limited said the U.S. Food and Drug Administration has completed an inspection of its Ankleshwar manufacturing facility in India, conducted from March 2 to March 7, 2026. The review closed with ...

Global pharmaceutical firm Lupin will expand its Florida operations with a a new manufacturing plant in Coral Springs. With a projected cumulative investment of $250 million, including research & ...

Drug maker Lupin on Friday said it has received an Establishment Inspection Report (EIR) from the US health regulator for its ...

This list honors female leaders who are redefining industries, breaking barriers and driving lasting change across various business sectors.

Catalyst Pharmaceuticals (NASDAQ:CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with Lupin Pharmaceuticals, putting an end to a patent lawsuit. The lawsuit was in ...

The Nifty Pharma index was trading slightly lower at 22,529.20, down 0.23 per cent, reflecting mixed sentiment across healthcare stocks. Despite the broader index weakness, a few constituents managed ...

Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Dasatinib Tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 ...

Ajit Mishra of Religare Broking provides crucial insights for navigating the current tumultuous market. With the Nifty 50 experiencing declines, he highlights opportunities in stocks like Lupin and ...